These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 15888513

  • 1. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG, Kopala LC, Rabinowitz J.
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [Abstract] [Full Text] [Related]

  • 2. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 3. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
    Weiden PJ, Cutler AJ, Polymeropoulos MH, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
    [Abstract] [Full Text] [Related]

  • 4. A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database.
    Fleischhacker WW, Lemmens P, van Baelen B.
    Pharmacopsychiatry; 2001 May; 34(3):104-10. PubMed ID: 11434401
    [Abstract] [Full Text] [Related]

  • 5. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A.
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [Abstract] [Full Text] [Related]

  • 6. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T, Liraud F, Verdoux H.
    Encephale; 2003 Oct; 29(5):430-7. PubMed ID: 14615692
    [Abstract] [Full Text] [Related]

  • 7. Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics?
    Henkel V, Mergl R, Schäfer M, Rujescu D, Möller HJ, Hegerl U.
    Pharmacopsychiatry; 2004 May; 37(3):110-8. PubMed ID: 15138894
    [Abstract] [Full Text] [Related]

  • 8. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH, Byun HJ.
    J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
    [Abstract] [Full Text] [Related]

  • 9. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK, Zalar B, Breskvar K, Dolzan V.
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [Abstract] [Full Text] [Related]

  • 10. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W.
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [Abstract] [Full Text] [Related]

  • 11. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A, Boussaïd N, Gassab L, Gaha L, Mechri A.
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [Abstract] [Full Text] [Related]

  • 12. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V, Serretti A, Mandelli L, Koprivsek J, Kastelic M, Plesnicar BK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1562-6. PubMed ID: 18573584
    [Abstract] [Full Text] [Related]

  • 13. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA, Brecher M, Paulsson B.
    Bipolar Disord; 2006 Oct 01; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [Abstract] [Full Text] [Related]

  • 14. Trajectories and antecedents of treatment response over time in early-episode psychosis.
    Levine SZ, Rabinowitz J.
    Schizophr Bull; 2010 May 01; 36(3):624-32. PubMed ID: 18849294
    [Abstract] [Full Text] [Related]

  • 15. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
    Juncal-Ruiz M, Ramirez-Bonilla M, Gomez-Arnau J, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, Martinez-Garcia O, Neergaard KD, Tabares-Seisdedos R, Crespo-Facorro B.
    Psychopharmacology (Berl); 2017 Sep 01; 234(17):2563-2570. PubMed ID: 28567698
    [Abstract] [Full Text] [Related]

  • 16. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G, Early Psychosis Global Working Group.
    Am J Psychiatry; 2005 May 01; 162(5):947-53. PubMed ID: 15863797
    [Abstract] [Full Text] [Related]

  • 17. Treatment response trajectories and their antecedents in recent-onset psychosis: a 2-year prospective study.
    Levine SZ, Rabinowitz J, Case M, Ascher-Svanum H.
    J Clin Psychopharmacol; 2010 Aug 01; 30(4):446-9. PubMed ID: 20631562
    [Abstract] [Full Text] [Related]

  • 18. [Duration of untreated psychosis in first-episode schizophrenia: clinical and cognitive correlates].
    Galińska B, Szulc A, Czernikiewicz A.
    Psychiatr Pol; 2005 Aug 01; 39(5):859-68. PubMed ID: 16358587
    [Abstract] [Full Text] [Related]

  • 19. Akathisia and suicidal ideation in first-episode schizophrenia.
    Seemüller F, Schennach R, Mayr A, Musil R, Jäger M, Maier W, Klingenberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Schlösser R, Schneider F, Ohmann C, Lewitzka U, Gaebel W, Möller HJ, Riedel M, German Study Group on First-Episode Schizophrenia.
    J Clin Psychopharmacol; 2012 Oct 01; 32(5):694-8. PubMed ID: 22926606
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
    Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM, HGDH Study Group.
    Am J Psychiatry; 2003 Aug 01; 160(8):1396-404. PubMed ID: 12900300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.